However, additional variants were found in other AD and non-AD risk genes, as follows: <i>SORL1</i> Glu270Lys was suggested as a risk mutation for AD and could increase amyloid peptide production and impair endosome functions. The gene discussed is SORL1; the disease is Alzheimer disease.